Abstract submission deadline: EXTENDED until 31 October 2020
Acceptance notification: 30 October 2020
Final programme: 2 November 2020
Registration deadline: 5 November 2020
DMCM2020: 12-14 November 2020
Please submit your abstract up to 400 words via this submission link by 31 October 2020 (extended).
The registration is free but mandatory. Please fill in the registration form here by 5 November 2020.
This webpage is the main entry point for accessing all events of the programme. We run this meeting using a combination of the virtual platform ZENODO and Webex Meetings. The live talks and the discussion panels will take place in Webex rooms, whereas the personal profiles of the participants and virtual posters (PDFs plus 7 minutes pre-recorded videos) will be displayed on the ZENODO platform. Upon agreement with the speakers, the live talks will be recorded and also displayed on the ZENODO platform right after the session.
The detailed instructions about profile generation, poster standards, video recordings, materials unloading to the ZENODO platform, etc. will be provided right after the abstract notification announcement.
We encourage everyone to submit the abstract and present the work. However, attendance without project presentation is also welcome. The attendees need to register to the meeting by 5 November 2020. The explanations on the virtual modalities of the presentations, discussion and posters will be available on the meeting website.
The key theme of the 2020 Disease Maps Community Meeting is COVID-19. The first day of the meeting will be dedicated to COVID-19, the second and the third days will be dedicated to ongoing community projects.
We also welcome talks, posters and discussions on other topics relevant to disease maps: ongoing disease map projects, related technologies and disease map applications.
The programme will contain keynotes, invited talks and talks selected from abstracts. We’ll hold several parallel discussion panels on the major burning topics in the field. All virtual posters will be exposed on the ZENODO platform.
Vassili Soumelis, MD, PhD
Hôpital St Louis, Paris, France
Olivier Lantz, MD, PhD
Institut Curie, Paris, France
Chris Sander, PhD
Dana–Farber Cancer Institute, Harvard Medical School, Boston, US
Maria-Jesus Martin, PhD
EMBL-EBI, Cambridge, UK
Dagmar Waltemath, PhD
Greifswald University Hospital, Greifswald, Germany
|The Curiosa study: high seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris
Olivier Lantz, Institut Curie, Paris, France
|Informatics resources for COVID-19 proteomics, viral evolution and drug effects
Chris Sander, Dana–Farber Cancer Institute, Harvard Medical School, Boston, US
|Deciphering molecular mechanisms of disease: a view on protein knowledge and disease maps
Maria-Jesus Martin, European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK
|Adding value to scientific results using COMBINE standards and guidelines for modelling and simulation in systems medicine
Dagmar Waltemath, Greifswald University Hospital, Greifswald, Germany
The programme will be available soon.
For any questions please contact organisers at email@example.com.
We would like to thank Marion Ferraez for her help with the design of the event page.